Despite intense interest in understanding the differentiation of vascu
lar smooth muscle, very little is known about the cellular and molecul
ar mechanisms that control differentiation of this cell type. Progress
in this field has been hampered by the lack of an inducible in vitro
system for study of the early steps of smooth muscle differentiation.
In this study, we describe a model system in which multipotential mous
e P19 embryonal carcinoma cells (P19s) can be induced to express multi
ple characteristics of differentiated smooth muscle. Treatment of P19s
with retinoic acid was associated with profound changes in cell morph
ology and with the appearance at high frequency of smooth muscle alpha
-actin-positive cells that were absent or present at extremely low fre
quency in parental P19s. A clonal line derived from retinoic acid-trea
ted P19s (9E11G) stably expressed multiple characteristics of differen
tiated smooth muscle, including smooth muscle-specific isoforms of alp
ha-actin and myosin heavy chain, as well as functional responses to th
e contractile agonists phenylephrine, angiotensin II, ATP, bradykinin,
histamine, platelet-derived growth factor (PDGF)-AA, and PDGF-BB. Add
itionally, 9E11G cells expressed transcripts for MHox, a muscle homeob
ox gene expressed in smooth, cardiac, and skeletal muscles, but not th
e skeletal muscle-specific regulatory factors, MyoD and myogenin. Resu
lts demonstrate that retinoic acid treatment of multipotential P19 cel
ls is associated with formation of cell lines that stably express mult
iple properties of differentiated smooth muscle. It remains to be dete
rmined whether retinoic acid has induced commitment to a smooth muscle
cell lineage as opposed to directly (or indirectly) activating genes
characteristic of differentiated smooth muscle cells. However, results
suggest that this cell system may be of use in attempting to identify
genes involved in controlling smooth muscle differentiation and/or li
neage determination.